In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer

Triple-negative breast cancer (TNBC) lacks prognostic and predictive markers. Here, the authors use phosphoproteomics to define kinases with distinct activity profiles in TNBC, demonstrating their prognostic value as well as their utility for simplifying TNBC classification and designing drug regime...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ivana Zagorac, Sara Fernandez-Gaitero, Renske Penning, Harm Post, Maria J. Bueno, Silvana Mouron, Luis Manso, Manuel M. Morente, Soledad Alonso, Violeta Serra, Javier Muñoz, Gonzalo Gómez-López, Jose Francisco Lopez-Acosta, Veronica Jimenez-Renard, Albert Gris-Oliver, Fatima Al-Shahrour, Elena Piñeiro-Yañez, Jose Luis Montoya-Suarez, Juan V. Apala, Amalia Moreno-Torres, Ramon Colomer, Ana Dopazo, Albert J. R. Heck, Maarten Altelaar, Miguel Quintela-Fandino
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/6508e17c6fdd4f1a8cecab535185385a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6508e17c6fdd4f1a8cecab535185385a
record_format dspace
spelling oai:doaj.org-article:6508e17c6fdd4f1a8cecab535185385a2021-12-02T14:38:53ZIn vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer10.1038/s41467-018-05742-z2041-1723https://doaj.org/article/6508e17c6fdd4f1a8cecab535185385a2018-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-05742-zhttps://doaj.org/toc/2041-1723Triple-negative breast cancer (TNBC) lacks prognostic and predictive markers. Here, the authors use phosphoproteomics to define kinases with distinct activity profiles in TNBC, demonstrating their prognostic value as well as their utility for simplifying TNBC classification and designing drug regimens.Ivana ZagoracSara Fernandez-GaiteroRenske PenningHarm PostMaria J. BuenoSilvana MouronLuis MansoManuel M. MorenteSoledad AlonsoVioleta SerraJavier MuñozGonzalo Gómez-LópezJose Francisco Lopez-AcostaVeronica Jimenez-RenardAlbert Gris-OliverFatima Al-ShahrourElena Piñeiro-YañezJose Luis Montoya-SuarezJuan V. ApalaAmalia Moreno-TorresRamon ColomerAna DopazoAlbert J. R. HeckMaarten AltelaarMiguel Quintela-FandinoNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-15 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Ivana Zagorac
Sara Fernandez-Gaitero
Renske Penning
Harm Post
Maria J. Bueno
Silvana Mouron
Luis Manso
Manuel M. Morente
Soledad Alonso
Violeta Serra
Javier Muñoz
Gonzalo Gómez-López
Jose Francisco Lopez-Acosta
Veronica Jimenez-Renard
Albert Gris-Oliver
Fatima Al-Shahrour
Elena Piñeiro-Yañez
Jose Luis Montoya-Suarez
Juan V. Apala
Amalia Moreno-Torres
Ramon Colomer
Ana Dopazo
Albert J. R. Heck
Maarten Altelaar
Miguel Quintela-Fandino
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
description Triple-negative breast cancer (TNBC) lacks prognostic and predictive markers. Here, the authors use phosphoproteomics to define kinases with distinct activity profiles in TNBC, demonstrating their prognostic value as well as their utility for simplifying TNBC classification and designing drug regimens.
format article
author Ivana Zagorac
Sara Fernandez-Gaitero
Renske Penning
Harm Post
Maria J. Bueno
Silvana Mouron
Luis Manso
Manuel M. Morente
Soledad Alonso
Violeta Serra
Javier Muñoz
Gonzalo Gómez-López
Jose Francisco Lopez-Acosta
Veronica Jimenez-Renard
Albert Gris-Oliver
Fatima Al-Shahrour
Elena Piñeiro-Yañez
Jose Luis Montoya-Suarez
Juan V. Apala
Amalia Moreno-Torres
Ramon Colomer
Ana Dopazo
Albert J. R. Heck
Maarten Altelaar
Miguel Quintela-Fandino
author_facet Ivana Zagorac
Sara Fernandez-Gaitero
Renske Penning
Harm Post
Maria J. Bueno
Silvana Mouron
Luis Manso
Manuel M. Morente
Soledad Alonso
Violeta Serra
Javier Muñoz
Gonzalo Gómez-López
Jose Francisco Lopez-Acosta
Veronica Jimenez-Renard
Albert Gris-Oliver
Fatima Al-Shahrour
Elena Piñeiro-Yañez
Jose Luis Montoya-Suarez
Juan V. Apala
Amalia Moreno-Torres
Ramon Colomer
Ana Dopazo
Albert J. R. Heck
Maarten Altelaar
Miguel Quintela-Fandino
author_sort Ivana Zagorac
title In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
title_short In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
title_full In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
title_fullStr In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
title_full_unstemmed In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
title_sort in vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/6508e17c6fdd4f1a8cecab535185385a
work_keys_str_mv AT ivanazagorac invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT sarafernandezgaitero invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT renskepenning invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT harmpost invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT mariajbueno invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT silvanamouron invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT luismanso invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT manuelmmorente invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT soledadalonso invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT violetaserra invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT javiermunoz invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT gonzalogomezlopez invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT josefranciscolopezacosta invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT veronicajimenezrenard invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT albertgrisoliver invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT fatimaalshahrour invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT elenapineiroyanez invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT joseluismontoyasuarez invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT juanvapala invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT amaliamorenotorres invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT ramoncolomer invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT anadopazo invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT albertjrheck invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT maartenaltelaar invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
AT miguelquintelafandino invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer
_version_ 1718390837537144832